A5060086548- Metabolism and Genetic Disorders
- Folate and B Vitamins Research
- Cardiac Imaging and Diagnostics
- Biochemical and Molecular Research
- Glycogen Storage Diseases and Myoclonus
- Oral and gingival health research
- Diet and metabolism studies
- Genetics and Neurodevelopmental Disorders
- Gestational Diabetes Research and Management
- Cardiovascular Disease and Adiposity
- Diabetes Management and Research
- Cardiovascular Function and Risk Factors
- Iron Metabolism and Disorders
- Genomics and Rare Diseases
- Food Security and Health in Diverse Populations
- Amino Acid Enzymes and Metabolism
- Coronary Interventions and Diagnostics
- Trace Elements in Health
- Liver Disease Diagnosis and Treatment
- Cardiac pacing and defibrillation studies
- Mitochondrial Function and Pathology
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
University of Minnesota
2023
University of St. Thomas - Minnesota
2023
Ultragenyx Pharmaceutical (United States)
2020-2021
BACKGROUND: Randomized trials in obstructive coronary artery disease (CAD) have largely shown no prognostic benefit from revascularization. Although there are several potential reasons for the lack of benefit, an underexplored possible reason is presence coincidental nonischemic cardiomyopathy (NICM). We investigated prevalence and significance NICM patients with CAD (CAD-NICM). METHODS: conducted a registry study consecutive on angiography who underwent contrast-enhanced cardiovascular...
Introduction: Randomized trials in obstructive coronary artery disease (CAD) have largely shown no prognostic benefit from revascularization. While there are several potential reasons for the lack of revascularization, an underexplored possibility is presence coexisting nonischemic myocardial pathology. Aim: We aimed to investigate prevalence and significance cardiomyopathy (NICM) CAD. Methods: studied a large cohort consecutive patients with CAD on angiography who had cardiovascular...
Introduction: Elevated fasting blood glucose in gestational diabetes (GDM) is the strongest predictor of adverse pregnancy outcomes but difficult to treat. We assessed effectiveness and safety a novel patient-led insulin dose titration algorithm, targeting rapid reduction glucose. Research Design Methods: In women with GDM commenced on insulin, we initiated approach basal titration. Women were asked increase their by 4 units after every elevated (>90 mg/dL). retrospectively reviewed...